Theravance Biopharma announces annual general meeting

• Theravance Biopharma schedules annual general meeting for June 12, 2026 in Dublin, Ireland.
• Shareholders will vote on election of six directors, including Laurie Smaldone Alsup, Susannah Gray, Dean J. Mitchell.
• Other items include ratification of Ernst & Young as independent auditor for fiscal year ending Dec. 31, 2026.
• Meeting agenda also includes non-binding advisory vote on named executive officer compensation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Theravance Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-050454), on April 28, 2026, and is solely responsible for the information contained therein.